Clinical and Pathologic Features Associated with Invasive Breast Carcinoma with 2018 ASCO/CAP Group ISH 2 Results (HER2/CEP17 ratio ≥2.0 and Average HER2 Copy Number of <4.0)

被引：0
|
作者：
Hoda, Raza [1 ]
McIntire, Patrick [1 ]
Komforti, Miglena [1 ]
Downs-Kelly, Erinn [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
100
引用
收藏
页码：111 / 113
页数：3
相关论文
共 50 条
  • [1] Clinical and Pathologic Features Associated with Invasive Breast Carcinoma with 2018 ASCO/CAP Group ISH 2 Results (HER2/CEP17 ratio ≥2.0 and Average HER2 Copy Number of <4.0)
    Hoda, Raza
    McIntire, Patrick
    Komforti, Miglena
    Downs-Kelly, Erinn
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 111 - 113
  • [2] HER2 positive (HER2/CEP17 ratio≥2.0) invasive mammary carcinomas with average <4.0 HER2 and <2.0 CEP17 signals/cell: Clinicopathologic features, correlation with HER2 immunohistochemistry and response to neoadjuvant chemotherapy
    Livasy, Chad A.
    Limentani, Kimberly
    Calhoun, Benjamin C.
    Limentani, Steven
    CANCER RESEARCH, 2015, 75
  • [3] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number <4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    MODERN PATHOLOGY, 2018, 31 : 117 - 117
  • [4] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number <4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    LABORATORY INVESTIGATION, 2018, 98 : 117 - 117
  • [5] Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2/CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0
    Hoda, Raza S.
    Brogi, Edi
    Xu, Jin
    Ventura, Katia
    Ross, Dara S.
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah Y.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (05) : 597 - 601
  • [6] A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
    Zhou, Shuling
    Lv, Hong
    Li, Anqi
    Li, Ming
    Zhong, Siyuan
    Lu, Hongfen
    Zhou, Xiaoyan
    Bai, Qianming
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [7] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio <2, HER2 Copy Number ≥4 and <6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    MODERN PATHOLOGY, 2019, 32
  • [8] Breast Cancer With a HER2 IHC2+and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event
    Liu, Yuanyuan
    Wu, Shafei
    Shi, Xiaohua
    Mao, Feng
    Zeng, Xuan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio <2, HER2 Copy Number ≥4 and <6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    LABORATORY INVESTIGATION, 2019, 99
  • [10] Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [HER2]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average HER2 Copy Number <4.0)
    Hoda, Raza S.
    Zarei, Shabnam
    McIntire, Patrick J.
    Sprague, Cathy
    Mekhail, Yasmin
    Carlson, Diane L.
    Komforti, Miglena K.
    Downs-Kelly, Erinn P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (06) : 701 - 709
12345